STADA Emerging Markets Expands in the MENA Region!
Exciting developments are happening as STADA makes a strategic move in the #MENA region!
The #German pharmaceutical giant has acquired #FITO from LEO Pharma, a trusted product for treating #Burns, #Ulcers, and #Wounds. This acquisition includes FITO’s existing operations in key markets such as #Egypt, #Kuwait, #Oman, #SaudiArabia, and the #UnitedArabEmirates.
But the expansion doesn’t stop there! STADA is also set to enter other important markets across the region, including #Algeria, #Bahrain, #Iraq, #Kenya, #Lebanon, #Libya, #Mauritius, #Morocco, #Pakistan, #Palestine, #Qatar, #Tunisia, and #Yemen.
This move significantly strengthens STADA's #ConsumerHealthcare presence across MENA, positioning the company as a major player in the region. By leveraging FITO's potential and STADA's marketing and sales expertise, we can anticipate substantial growth and enhanced patient care.
STADA EVP Stéphane Jacqmin Emerging Markets: “We look forward to leveraging our local marketing and sales strength to develop the full potential of this strong brand in the many markets of the MENA region. This will strengthen STADA’s role as the partner of choice in consumer healthcare and support our growth in the region.”
In addition to this acquisition, STADA MENA has also entered into a supply and distribution agreement with Farmaceutici DAMOR S.p.A, Italy.
This news follows another exciting collaboration with ADCAN Pharma to #Produce and #Distribute a range of consumer healthcare products in the UAE. It’s clear that STADA is dedicated to expanding its footprint and delivering high-quality healthcare solutions throughout the MENA region.
STADA Group STADA Emerging Markets
#HealthcareInnovation #PharmaNews #STADA #MENAExpansion #PatientCare
STADA expands MENA footprint with FITO acquisition
https://www.healthcaremea.com
One year ago...
Exciting developments are happening as STADA makes a strategic move in the #MENA region!
The #German pharmaceutical giant has acquired #FITO from LEO Pharma, a trusted product for treating #Burns, #Ulcers, and #Wounds. This acquisition includes FITO’s existing operations in key markets such as #Egypt, #Kuwait, #Oman, #SaudiArabia, and the #UnitedArabEmirates.
But the expansion doesn’t stop there! STADA is also set to enter other important markets across the region, including #Algeria, #Bahrain, #Iraq, #Kenya, #Lebanon, #Libya, #Mauritius, #Morocco, #Pakistan, #Palestine, #Qatar, #Tunisia, and #Yemen.
This move significantly strengthens STADA's #ConsumerHealthcare presence across MENA, positioning the company as a major player in the region. By leveraging FITO's potential and STADA's marketing and sales expertise, we can anticipate substantial growth and enhanced patient care.
STADA EVP Stéphane Jacqmin Emerging Markets: “We look forward to leveraging our local marketing and sales strength to develop the full potential of this strong brand in the many markets of the MENA region. This will strengthen STADA’s role as the partner of choice in consumer healthcare and support our growth in the region.”
In addition to this acquisition, STADA MENA has also entered into a supply and distribution agreement with Farmaceutici DAMOR S.p.A, Italy.
This news follows another exciting collaboration with ADCAN Pharma to #Produce and #Distribute a range of consumer healthcare products in the UAE. It’s clear that STADA is dedicated to expanding its footprint and delivering high-quality healthcare solutions throughout the MENA region.
STADA Group STADA Emerging Markets
#HealthcareInnovation #PharmaNews #STADA #MENAExpansion #PatientCare
STADA expands MENA footprint with FITO acquisition
https://www.healthcaremea.com
One year ago...
1
